Permatec Pharma AG

With headquarters in Switzerland, Permatec is represented in Europe (France, Italy, Switzerland), and South America (Argentina). Permatec plans to set up US operations in the near future.
A unique gathering of competences allows Permatec to carry out proprietary and non-proprietary development projects from the pre-formulation stage to the preparation of registration files. The patent is a major tool to offer additional protection and market advantage to our clients. Permatec's strategy is to apply for patent protection whenever relevant.
Permatec's patent portfolio includes granted and pending patents in various technologies. Using its diversified drug delivery know-how, Permatec is able to tailor kinetic profiles according to drug specifics.

Activity:

- Contract Research
- Licensing & Business Development
- Research & Development

Product / Technology type(s) covered:

- Drug delivery
- Pharmaceuticals / Therapeutics
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Europe

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: